RecruitingPhase 1NCT07389044

A Study on IB-001 Dose Response and Tolerability in Healthy Adults and Those With Chronic Hepatitis B

Studying Chronic graft versus host disease

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
IntegerBio
Principal Investigator
Edward Gane, MBChB, MD, FRACP, MNZ
New Zealand Clinical Research
Intervention
IB-001(drug)
Enrollment
90 target
Eligibility
18-70 years · All sexes
Timeline
20262027

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT07389044 on ClinicalTrials.gov

Other trials for Chronic graft versus host disease

Additional recruiting or active studies for the same condition.

See all trials for Chronic graft versus host disease

← Back to all trials